Evidence map›Paper›PMID 38790431›Full record

ReviewBrain sciences2024

Deep Brain Stimulation for Primary Refractory Tinnitus: A Systematic Review.

Landon Basner, Jasper V Smit, Daniel M Zeitler, Seth R Schwartz, Katie Krause, Aiyush Bansal, Farrokh Farrokhi

Abstract readReview
In one paragraph

Review in Brain sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Deep brain stimulation of the medial geniculate body for refractory tinnitus: A feasibility study.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Landon BasnerUniversity of Washington School of Medicine, Seattle, WA 98195, USA.
Jasper V SmitDepartment of Ear, Nose and Throat Surgery, Zuyderland Medical Center, 6419 PC Heerlen, The Netherlands.
Daniel M ZeitlerDepartment of Otolaryngology, Virginia Mason Medical Center, Seattle, WA 98101, USA.
Seth R SchwartzDepartment of Otolaryngology, Virginia Mason Medical Center, Seattle, WA 98101, USA.
Katie KrauseCenter for Neurosciences and Spine, Virginia Mason Franciscan Health, Seattle, WA 98101, USA.
Aiyush BansalCenter for Neurosciences and Spine, Virginia Mason Franciscan Health, Seattle, WA 98101, USA.ORCID 0000-0002-6787-5501
Farrokh FarrokhiCenter for Neurosciences and Spine, Virginia Mason Franciscan Health, Seattle, WA 98101, USA.ORCID 0000-0002-7559-3934

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundtinnitus is a common and often debilitating condition with limited evidence-based treatment options. Deep brain stimulation (DBS) is an approved treatment modality for certain neurological conditions; its experimental use as a treatment modality for severe tinnitus is novel and beginning to show promise. This systematic review focuses on the current evidence for the safety and efficacy of DBS for treatment of refractory tinnitus.

methodsa systematic search in PubMed and EMBASE was performed to identify peer-reviewed studies on DBS of non-cortical structures for the primary indication of tinnitus treatment. Three studies were identified as meeting these criteria, one of which had two related sub-studies.

resultsseven patients with available data who underwent DBS for tinnitus were identified. DBS targets included nucleus accumbens (NAc), ventral anterior limb of the internal capsule (vALIC), caudate nucleus, and the medial geniculate body (MGB) of the thalamus. All studies used the Tinnitus Functional Index (TFI) as a primary outcome measure. DBS of the caudate was most commonly reported (n = 5), with a mean TFI improvement of 23.3 points. Only one subject underwent DBS targeting the NAc/vALIC (extrapolated TFI improvement 46.8) and one subject underwent DBS targeting the MGB (TFI improvement 59 points).

conclusionsDBS is a promising treatment option for refractory subjective tinnitus, with early data, from small patient cohorts in multiple studies, suggesting its safety and efficacy. Further studies with a larger patient population are needed to support this safety and efficacy before implementing this treatment to daily practice.

Indexed as

brain implantdeep brain stimulationneuromodulationtinnitus

Identifiers

PMID38790431
PMCPMC11118089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.